Olympus Announces FDA Clearance of RenaFlex™, Its First Single-use Flexible Ureteroscope
Posted:
Olympus Corporation single-use flexible ureteroscopy system, RenaFlex™, has received clearance from the U.S. Food and Drug Administration (FDA) and will soon be available in the United States.
This product assists in the diagnosis and treatment of urological conditions such as #Urolithiasis.
Sanome has secured Class IIb CE certification and MHRA approval for MEMORI - an AI-enabled warning system for the early prediction/prevention of healthcare‑associated infections (HAIs).
Read more here.
Driven by demand, Conexen are hoping to launch a new community in Manchester this October. They have an amazing team of local executives ready to go and excited to bring everybody in life sciences, biopharma and health together.
Contact them:…
Attendees
Sponsors and Exhibitors
Contact us